IL6 and Huntington disease: For both IL-6 and IL-1B, the HD patients exhibited significantly higher levels when compared to PM patients, but not compared to NC subjects (IL-6, log pg/mL = 1.42 ± 0.51 vs. 1.00 ± 0.43; p < 0.05; IL-1B, log pg/mL= 2.71 ± 0.41 pg/mL vs. 2.53 ± 0.29 p < 0.05) (Figure 1).